The European Patent Office (EPO) has granted patent EP4169467B1, titled 'Path planning device for multi-needle joint cryoablation.' This patent, effective March 18, 2026, covers an invention related to medical devices and incorporates classifications in AI and computing (G06N). The patent is designated for multiple European states, indicating its potential cross-border applicability within the EU.

This grant signifies the formal recognition of intellectual property rights for a specific technological innovation in the medical field. For medical device manufacturers and healthcare providers operating within the designated states, this patent may impact the development, manufacturing, and deployment of similar cryoablation technologies. Compliance officers should note this patent's existence as it may influence product roadmaps, licensing agreements, and freedom-to-operate analyses concerning related medical devices.